US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acumen Pharmaceuticals, Inc.

1.53

-0.0050-0.33%

Volume:150.54K

Turnover:227.54K

Market Cap:92.37M

PE:-0.67

High:1.55

Open:1.52

Low:1.47

Close:1.53

52wk High:3.36

52wk Low:0.8551

Shares:60.57M

Float Shares:32.93M

Volume Ratio:0.60

T/O Rate:0.46%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.2658

EPS(LYR):-1.7051

ROE:-75.71%

ROA:-39.06%

PB:0.79

PE(LYR):-0.89

Loading ...

Overview Company News Filings

Acumen Pharmaceuticals Initiated at Buy by Citigroup

Acumen initiated with a Buy at Citi

Acumen Pharmaceuticals Inc. Conducted Annual Stockholders Meeting

Acumen Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Acumen Pharmaceuticals Inc. Unveils Presentation on Sabirnetug Antibody Targeting Toxic Amyloid Beta Oligomers for Early Alzheimer's Treatment

Acumen Pharmaceuticals Q1 GAAP EPS $(0.48) Beats $(0.54) Estimate

BRIEF-Acumen Pharmaceuticals, Inc. Q1 Income From Operations USD -30.37 Million

Acumen Pharmaceuticals Reports Q1 2025 Net Loss of $28.8 Million, Doubling from Previous Year

Press Release: Acumen Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Highlights

Acumen Pharmaceuticals Inc expected to post a loss of 54 cents a share - Earnings Preview

Acumen Pharmaceuticals’ Promising Alzheimer’s Strategy Earns Buy Rating with Revised Price Target

Acumen Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

UBS Cuts Price Target on Acumen Pharmaceuticals to $4 From $6, Keeps Buy Rating

MT Newswires Live

Acumen Pharmaceuticals Inc (ABOS) Q4 2024 Earnings Call Highlights: Strong Financial Position ...

Q4 2024 Acumen Pharmaceuticals Inc Earnings Call

Thomson Reuters StreetEvents

Acumen Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Acumen Pharmaceuticals FY 2024 EPS $(1.71) Misses $(1.55) Estimate

BRIEF-Acumen Pharmaceuticals, Inc. FY Income From Operations USD -114.017 Million

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2024 and Business Highlights

BRIEF-Acumen Pharmaceuticals Completes Enrollment Of Altitude-Ad, A Phase 2 Clinical Trial Of Sabirnetug (Acu193) In Early Alzheimer’S Disease

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ABOS/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ABOS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABOS\",,,,,undefined,":{"symbol":"ABOS","market":"US","secType":"STK","nameCN":"Acumen Pharmaceuticals, Inc.","latestPrice":1.525,"timestamp":1756150011826,"preClose":1.53,"halted":0,"volume":150535,"delay":0,"floatShares":32929494,"shares":60573425,"eps":-2.265848,"marketStatus":"Trading","change":-0.005,"latestTime":"08-25 15:27:08 EDT","open":1.52,"high":1.545,"low":1.47,"amount":227536.2868625,"amplitude":0.04902,"askPrice":1.53,"askSize":301,"bidPrice":1.52,"bidSize":68,"shortable":3,"etf":0,"ttmEps":-2.265848,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1756152000000},"marketStatusCode":2,"adr":0,"listingDate":1625112000000,"exchange":"NASDAQ","adjPreClose":1.53,"preHourTrading":{"tag":"盘前","latestPrice":1.55,"preClose":1.53,"latestTime":"09:07 EDT","volume":109,"amount":166.8300045,"timestamp":1756127220152},"postHourTrading":{"tag":"盘后","latestPrice":1.5,"preClose":1.53,"latestTime":"19:55 EDT","volume":2912,"amount":4447.6851,"timestamp":1755906938621},"volumeRatio":0.597425,"impliedVol":0.145,"impliedVolPercentile":0.012},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ABOS\",,,,,undefined,":{"symbol":"ABOS","floatShares":32929494,"roa":"-39.06%","roe":"-75.71%","lyrEps":-1.705106,"volumeRatio":0.597425,"shares":60573425,"dividePrice":0,"high":1.545,"amplitude":0.04902,"preClose":1.53,"low":1.47,"week52Low":0.8551,"pbRate":"0.79","week52High":3.36,"institutionHeld":0,"latestPrice":1.525,"committee":-0.631436,"eps":-2.265848,"divideRate":0,"volume":150535,"delay":0,"ttmEps":-2.265848,"open":1.52,"prevYearClose":1.72,"prevWeekClose":1.53,"prevMonthClose":1.4,"prevQuarterClose":1.16,"fiveDayClose":1.43,"twentyDayClose":1.46,"sixtyDayClose":1.05},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ABOS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-12","symbol":"ABOS","fiscalQuarterEnding":"2025/06","expectedEps":-0.54,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754971200000,"reportTimeType":"pre","actualEps":-0.68},{"market":"US","date":"2025-05-13","symbol":"ABOS","fiscalQuarterEnding":"2025/03","expectedEps":-0.56,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"pre","actualEps":-0.48},{"market":"US","date":"2025-03-27","symbol":"ABOS","fiscalQuarterEnding":"2024/12","expectedEps":-0.47,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"pre","actualEps":-0.62},{"market":"US","date":"2024-11-12","symbol":"ABOS","fiscalQuarterEnding":"2024/09","expectedEps":-0.36,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-0.5},{"market":"US","date":"2024-08-13","symbol":"ABOS","fiscalQuarterEnding":"2024/06","expectedEps":-0.28,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1723521600000,"reportTimeType":"pre","actualEps":-0.34}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ABOS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ABOS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0.3333,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6667,"analysts":6,"updateTime":1750219200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ABOS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ABOS","date":"2025-08-22","current":-0.602787,"percent":0.965312,"low":-24.285355,"twenty":-6.348535,"median":-3.530944,"eighty":-1.613202,"high":-0.510632,"avg":-4.376742,"sd":3.833764,"marketCap":82379858},"quantilePoints":[{"date":"2021-07-02","current":-24.285355,"twenty":-23.282602,"median":-17.962584,"eighty":-17.962584,"marketCap":783858402},{"date":"2021-07-09","current":-22.632801,"twenty":-23.49497,"median":-22.453176,"eighty":-17.962584,"marketCap":730518925},{"date":"2021-07-16","current":-21.387398,"twenty":-22.821186,"median":-22.058,"eighty":-19.615112,"marketCap":690321058},{"date":"2021-07-23","current":-20.453346,"twenty":-22.762131,"median":-21.9622,"eighty":-20.489271,"marketCap":660172658},{"date":"2021-07-30","current":-18.537342,"twenty":-22.651961,"median":-21.004198,"eighty":-18.192479,"marketCap":598329786},{"date":"2021-08-06","current":-17.974516,"twenty":-22.525026,"median":-20.513221,"eighty":-17.962584,"marketCap":580163442},{"date":"2021-08-13","current":-18.166116,"twenty":-22.280735,"median":-19.189981,"eighty":-17.931406,"marketCap":586347730},{"date":"2021-08-20","current":-7.634154,"twenty":-22.15859,"median":-18.285866,"eighty":-17.71346,"marketCap":699288543},{"date":"2021-08-27","current":-8.252662,"twenty":-22.03884,"median":-17.992479,"eighty":-8.058274,"marketCap":755943865},{"date":"2021-09-03","current":-6.887527,"twenty":-21.617319,"median":-17.962584,"eighty":-7.680984,"marketCap":630897476},{"date":"2021-09-10","current":-7.510453,"twenty":-21.349078,"median":-17.950566,"eighty":-7.666847,"marketCap":687957479},{"date":"2021-09-17","current":-7.170273,"twenty":-21.061678,"median":-17.84279,"eighty":-7.521056,"marketCap":656797052},{"date":"2021-09-24","current":-7.130512,"twenty":-20.654527,"median":-17.663165,"eighty":-7.137581,"marketCap":653154924},{"date":"2021-10-01","current":-6.746154,"twenty":-20.541962,"median":-12.845778,"eighty":-7.060709,"marketCap":617947688},{"date":"2021-10-08","current":-5.942094,"twenty":-20.489271,"median":-8.093617,"eighty":-6.829211,"marketCap":544295770},{"date":"2021-10-15","current":-5.986273,"twenty":-20.209056,"median":-7.868304,"eighty":-6.749688,"marketCap":548342578},{"date":"2021-10-22","current":-6.35296,"twenty":-19.320509,"median":-7.709259,"eighty":-6.596828,"marketCap":581931091},{"date":"2021-10-29","current":-6.207168,"twenty":-18.460702,"median":-7.618691,"eighty":-6.547348,"marketCap":568576622},{"date":"2021-11-05","current":-6.573855,"twenty":-18.321792,"median":-7.510453,"eighty":-6.499634,"marketCap":602165134},{"date":"2021-11-12","current":-5.721198,"twenty":-18.237966,"median":-7.159228,"eighty":-6.436016,"marketCap":524061726},{"date":"2021-11-19","current":-4.290171,"twenty":-18.103846,"median":-7.121676,"eighty":-6.359144,"marketCap":399037384},{"date":"2021-11-26","current":-3.598348,"twenty":-18.003256,"median":-7.081915,"eighty":-6.245163,"marketCap":334689571},{"date":"2021-12-03","current":-3.398198,"twenty":-17.97213,"median":-6.960422,"eighty":-6.12853,"marketCap":316073222},{"date":"2021-12-10","current":-3.063165,"twenty":-17.962584,"median":-6.808005,"eighty":-5.947395,"marketCap":284911073},{"date":"2021-12-17","current":-2.993547,"twenty":-17.962584,"median":-6.759408,"eighty":-5.733568,"marketCap":278435822},{"date":"2021-12-23","current":-3.076218,"twenty":-17.962584,"median":-6.746154,"eighty":-4.668715,"marketCap":286125183},{"date":"2021-12-31","current":-2.941334,"twenty":-17.950566,"median":-6.693139,"eighty":-3.915978,"marketCap":273579383},{"date":"2022-01-07","current":-2.501875,"twenty":-17.902666,"median":-6.569437,"eighty":-3.533082,"marketCap":232704357},{"date":"2022-01-14","current":-2.340884,"twenty":-17.84279,"median":-6.560601,"eighty":-3.298123,"marketCap":217730337},{"date":"2022-01-21","current":-2.253863,"twenty":-17.84279,"median":-6.529676,"eighty":-3.128431,"marketCap":209636273},{"date":"2022-01-28","current":-2.179894,"twenty":-17.76615,"median":-6.50096,"eighty":-3.056203,"marketCap":202756318},{"date":"2022-02-04","current":-2.166841,"twenty":-17.67993,"median":-6.441318,"eighty":-3.000509,"marketCap":201542208},{"date":"2022-02-11","current":-2.345235,"twenty":-17.567365,"median":-6.368422,"eighty":-2.938723,"marketCap":218135040},{"date":"2022-02-18","current":-2.571492,"twenty":-17.399714,"median":-6.357377,"eighty":-2.830816,"marketCap":239179608},{"date":"2022-02-25","current":-2.488821,"twenty":-11.942176,"median":-6.255765,"eighty":-2.557568,"marketCap":231490247},{"date":"2022-03-04","current":-2.184245,"twenty":-8.282704,"median":-6.180661,"eighty":-2.531462,"marketCap":203161021},{"date":"2022-03-11","current":-2.397448,"twenty":-8.157235,"median":-6.127646,"eighty":-2.498394,"marketCap":222991479},{"date":"2022-03-18","current":-2.789046,"twenty":-8.090966,"median":-5.966392,"eighty":-2.491432,"marketCap":259414770},{"date":"2022-03-25","current":-2.236458,"twenty":-7.98582,"median":-5.942094,"eighty":-2.48534,"marketCap":208017460},{"date":"2022-04-01","current":-1.613202,"twenty":-7.858585,"median":-5.752123,"eighty":-2.459234,"marketCap":162297812},{"date":"2022-04-08","current":-1.609179,"twenty":-7.787898,"median":-4.68612,"eighty":-2.395708,"marketCap":161893080},{"date":"2022-04-14","current":-1.59711,"twenty":-7.743719,"median":-4.477268,"eighty":-2.375693,"marketCap":160678881},{"date":"2022-04-22","current":-1.653432,"twenty":-7.680984,"median":-4.068266,"eighty":-2.340884,"marketCap":166345139},{"date":"2022-04-29","current":-1.55375,"twenty":-7.636805,"median":-3.598348,"eighty":-2.293893,"marketCap":156316536},{"date":"2022-05-06","current":-1.465194,"twenty":-7.621784,"median":-3.48522,"eighty":-2.261695,"marketCap":147407303},{"date":"2022-05-13","current":-1.340411,"twenty":-7.576721,"median":-3.311177,"eighty":-2.229496,"marketCap":134853384},{"date":"2022-05-20","current":-1.703502,"twenty":-7.526357,"median":-3.263314,"eighty":-2.181634,"marketCap":140944377},{"date":"2022-05-27","current":-1.742663,"twenty":-7.455671,"median":-3.076218,"eighty":-2.166841,"marketCap":144184478},{"date":"2022-06-03","current":-1.801405,"twenty":-7.332853,"median":-3.063165,"eighty":-1.916589,"marketCap":149044629},{"date":"2022-06-10","current":-1.879727,"twenty":-7.165855,"median":-3.024005,"eighty":-1.875701,"marketCap":155524830},{"date":"2022-06-17","current":-1.61539,"twenty":-7.14465,"median":-3.002249,"eighty":-1.786719,"marketCap":133654151},{"date":"2022-06-24","current":-1.835671,"twenty":-7.130512,"median":-2.971792,"eighty":-1.762051,"marketCap":151879717},{"date":"2022-07-01","current":-2.305602,"twenty":-7.121676,"median":-2.934807,"eighty":-1.786719,"marketCap":190760925},{"date":"2022-07-08","current":-2.932178,"twenty":-7.093402,"median":-2.93023,"eighty":-1.786719,"marketCap":242602535},{"date":"2022-07-15","current":-3.079032,"twenty":-7.082799,"median":-2.928281,"eighty":-1.798468,"marketCap":254752912},{"date":"2022-07-22","current":-3.074136,"twenty":-7.053641,"median":-2.93023,"eighty":-1.805321,"marketCap":254347900},{"date":"2022-07-29","current":-2.662946,"twenty":-7.035969,"median":-2.893472,"eighty":-1.8063,"marketCap":220326843},{"date":"2022-08-05","current":-2.555254,"twenty":-6.916685,"median":-2.888122,"eighty":-1.829797,"marketCap":211416566},{"date":"2022-08-12","current":-2.643366,"twenty":-6.866321,"median":-2.848961,"eighty":-1.866889,"marketCap":218706793},{"date":"2022-08-19","current":-6.140146,"twenty":-6.966193,"median":-2.888122,"eighty":-1.87872,"marketCap":193604932},{"date":"2022-08-26","current":-7.052176,"twenty":-7.035969,"median":-2.893472,"eighty":-1.891475,"marketCap":222362150},{"date":"2022-09-02","current":-7.411849,"twenty":-7.058124,"median":-2.93023,"eighty":-1.921825,"marketCap":233703025},{"date":"2022-09-09","current":-8.657862,"twenty":-7.09585,"median":-2.939203,"eighty":-1.943364,"marketCap":272991055},{"date":"2022-09-16","current":-7.052176,"twenty":-7.137581,"median":-2.966444,"eighty":-1.985462,"marketCap":222362150},{"date":"2022-09-23","current":-5.947463,"twenty":-7.12521,"median":-2.997898,"eighty":-2.053302,"marketCap":187529464},{"date":"2022-09-30","current":-12.884029,"twenty":-7.15702,"median":-3.015395,"eighty":-2.099834,"marketCap":406246333},{"date":"2022-10-07","current":-12.614274,"twenty":-7.388838,"median":-3.045761,"eighty":-2.133486,"marketCap":397740677},{"date":"2022-10-14","current":-10.160785,"twenty":-7.596303,"median":-3.064346,"eighty":-2.159688,"marketCap":320379710},{"date":"2022-10-21","current":-9.813957,"twenty":-7.732232,"median":-3.076218,"eighty":-2.166841,"marketCap":309443867},{"date":"2022-10-28","current":-9.197373,"twenty":-7.820986,"median":-3.141484,"eighty":-2.166841,"marketCap":290002367},{"date":"2022-11-04","current":-8.169734,"twenty":-8.037325,"median":-3.289421,"eighty":-2.169452,"marketCap":257599868},{"date":"2022-11-11","current":-8.734935,"twenty":-8.202905,"median":-3.398198,"eighty":-2.176413,"marketCap":275421243},{"date":"2022-11-18","current":-6.490146,"twenty":-8.124064,"median":-3.535258,"eighty":-2.182505,"marketCap":248825726},{"date":"2022-11-25","current":-6.607567,"twenty":-8.09185,"median":-3.757163,"eighty":-2.187726,"marketCap":253327507},{"date":"2022-12-02","current":-5.977767,"twenty":-8.054616,"median":-4.220554,"eighty":-2.201649,"marketCap":229181590},{"date":"2022-12-09","current":-6.532845,"twenty":-7.992466,"median":-4.572991,"eighty":-2.219924,"marketCap":250462738},{"date":"2022-12-16","current":-6.105861,"twenty":-7.961637,"median":-5.156037,"eighty":-2.229496,"marketCap":234092624},{"date":"2022-12-23","current":-5.561458,"twenty":-7.929869,"median":-5.598819,"eighty":-2.233847,"marketCap":213220729},{"date":"2022-12-30","current":-5.764275,"twenty":-7.898102,"median":-5.598819,"eighty":-2.239939,"marketCap":220996533},{"date":"2023-01-06","current":-5.593482,"twenty":-7.822905,"median":-5.620168,"eighty":-2.253863,"marketCap":214448488},{"date":"2023-01-13","current":-6.66094,"twenty":-7.819707,"median":-5.703399,"eighty":-2.258214,"marketCap":255373772},{"date":"2023-01-20","current":-6.105861,"twenty":-7.811989,"median":-5.732251,"eighty":-2.265176,"marketCap":234092624},{"date":"2023-01-27","current":-5.817648,"twenty":-7.77923,"median":-5.773662,"eighty":-2.270397,"marketCap":223042797},{"date":"2023-02-03","current":-6.137885,"twenty":-7.767658,"median":-5.817648,"eighty":-2.274748,"marketCap":235320383},{"date":"2023-02-10","current":-6.084512,"twenty":-7.720746,"median":-5.860346,"eighty":-2.28606,"marketCap":233274118},{"date":"2023-02-17","current":-5.881695,"twenty":-7.652709,"median":-5.881695,"eighty":-2.2983,"marketCap":225498314},{"date":"2023-02-24","current":-5.593482,"twenty":-7.635921,"median":-5.838997,"eighty":-2.301318,"marketCap":214448488},{"date":"2023-03-03","current":-5.582807,"twenty":-7.615599,"median":-5.817648,"eighty":-2.301725,"marketCap":214039235},{"date":"2023-03-10","current":-4.86761,"twenty":-7.596303,"median":-5.817648,"eighty":-2.304051,"marketCap":186619295},{"date":"2023-03-17","current":-4.131064,"twenty":-7.55885,"median":-5.764275,"eighty":-2.311108,"marketCap":158380849},{"date":"2023-03-24","current":-4.184437,"twenty":-7.521056,"median":-5.732251,"eighty":-2.321021,"marketCap":160427113},{"date":"2023-03-31","current":-3.886544,"twenty":-7.451291,"median":-5.696476,"eighty":-2.334604,"marketCap":166561751},{"date":"2023-04-06","current":-3.656798,"twenty":-7.396509,"median":-5.678878,"eighty":-2.340884,"marketCap":156715736},{"date":"2023-04-14","current":-3.714235,"twenty":-7.347733,"median":-5.63618,"eighty":-2.342624,"marketCap":159177240},{"date":"2023-04-21","current":-3.829108,"twenty":-7.288533,"median":-5.625505,"eighty":-2.346976,"marketCap":164100248},{"date":"2023-04-28","current":-3.656798,"twenty":-7.222732,"median":-5.593482,"eighty":-2.360029,"marketCap":156715736},{"date":"2023-05-05","current":-3.876972,"twenty":-7.161437,"median":-5.593482,"eighty":-2.375693,"marketCap":166151501},{"date":"2023-05-12","current":-5.219914,"twenty":-7.141115,"median":-5.582807,"eighty":-2.377433,"marketCap":235073605},{"date":"2023-05-19","current":-5.092377,"twenty":-7.126978,"median":-5.566795,"eighty":-2.383554,"marketCap":229330096},{"date":"2023-05-26","current":-4.418252,"twenty":-7.114429,"median":-5.429439,"eighty":-2.39053,"marketCap":198971550},{"date":"2023-06-02","current":-4.554899,"twenty":-7.102566,"median":-5.219914,"eighty":-2.393967,"marketCap":205125310},{"date":"2023-06-09","current":-4.436471,"twenty":-7.097021,"median":-5.145256,"eighty":-2.397448,"marketCap":199792051},{"date":"2023-06-16","current":-5.110596,"twenty":-7.089836,"median":-5.134474,"eighty":-2.40528,"marketCap":230150597},{"date":"2023-06-23","current":-5.147036,"twenty":-7.086333,"median":-5.156037,"eighty":-2.436608,"marketCap":231791600},{"date":"2023-06-30","current":-4.381813,"twenty":-7.082799,"median":-5.134474,"eighty":-2.437538,"marketCap":197330548},{"date":"2023-07-07","current":-4.600448,"twenty":-7.064072,"median":-5.110596,"eighty":-2.437771,"marketCap":207176563},{"date":"2023-07-14","current":-5.575196,"twenty":-7.052176,"median":-5.110596,"eighty":-2.441687,"marketCap":251073379},{"date":"2023-07-21","current":-9.382079,"twenty":-7.085449,"median":-5.147036,"eighty":-2.448851,"marketCap":422512554},{"date":"2023-07-28","current":-9.253733,"twenty":-7.118052,"median":-5.210804,"eighty":-2.455753,"marketCap":416732628},{"date":"2023-08-04","current":-9.11897,"twenty":-7.240218,"median":-5.320122,"eighty":-2.463585,"marketCap":410663706},{"date":"2023-08-11","current":-8.752,"twenty":-7.404179,"median":-5.397952,"eighty":-2.467066,"marketCap":406906755},{"date":"2023-08-18","current":-7.965898,"twenty":-7.60092,"median":-5.429439,"eighty":-2.46806,"marketCap":370358476},{"date":"2023-08-25","current":-7.61739,"twenty":-7.695122,"median":-5.513668,"eighty":-2.473653,"marketCap":354155293},{"date":"2023-09-01","current":-7.492922,"twenty":-7.770568,"median":-5.575196,"eighty":-2.481859,"marketCap":348368442},{"date":"2023-09-07","current":-7.380902,"twenty":-7.767705,"median":-5.588145,"eighty":-2.487081,"marketCap":343160276},{"date":"2023-09-15","current":-6.85814,"twenty":-7.766715,"median":-5.593482,"eighty":-2.488821,"marketCap":318855501},{"date":"2023-09-22","current":-5.887296,"twenty":-7.732232,"median":-5.602525,"eighty":-2.490499,"marketCap":273718061},{"date":"2023-09-29","current":-5.19028,"twenty":-7.666847,"median":-5.593482,"eighty":-2.49255,"marketCap":241311695},{"date":"2023-10-06","current":-5.576128,"twenty":-7.637688,"median":-5.593482,"eighty":-2.494913,"marketCap":259250933},{"date":"2023-10-12","current":-5.177833,"twenty":-7.635038,"median":-5.579467,"eighty":-2.500134,"marketCap":240733009},{"date":"2023-10-20","current":-4.343904,"twenty":-7.620743,"median":-5.572132,"eighty":-2.501875,"marketCap":201961106},{"date":"2023-10-27","current":-4.007842,"twenty":-7.614901,"median":-5.561458,"eighty":-2.506226,"marketCap":186336608},{"date":"2023-11-03","current":-2.439556,"twenty":-7.6046,"median":-5.465632,"eighty":-2.494913,"marketCap":113422283},{"date":"2023-11-10","current":-2.315089,"twenty":-7.60092,"median":-5.420329,"eighty":-2.494913,"marketCap":107635432},{"date":"2023-11-17","current":-2.659529,"twenty":-7.580741,"median":-5.37478,"eighty":-2.491928,"marketCap":129625466},{"date":"2023-11-24","current":-2.815917,"twenty":-7.53696,"median":-5.352087,"eighty":-2.493172,"marketCap":137247792},{"date":"2023-12-01","current":-2.851561,"twenty":-7.510453,"median":-5.277407,"eighty":-2.501875,"marketCap":138985106},{"date":"2023-12-08","current":-3.338703,"twenty":-7.499934,"median":-5.233843,"eighty":-2.501875,"marketCap":162728395},{"date":"2023-12-15","current":-3.564452,"twenty":-7.477986,"median":-5.219914,"eighty":-2.514928,"marketCap":173731383},{"date":"2023-12-22","current":-3.754556,"twenty":-7.434321,"median":-5.195987,"eighty":-2.526809,"marketCap":182997056},{"date":"2023-12-29","current":-4.550617,"twenty":-7.40566,"median":-5.177833,"eighty":-2.530479,"marketCap":221797065},{"date":"2024-01-05","current":-4.776365,"twenty":-7.387091,"median":-5.160712,"eighty":-2.535132,"marketCap":232800053},{"date":"2024-01-12","current":-4.598143,"twenty":-7.374979,"median":-5.147036,"eighty":-2.538641,"marketCap":224113484},{"date":"2024-01-19","current":-4.372394,"twenty":-7.334851,"median":-5.132811,"eighty":-2.542883,"marketCap":213110496},{"date":"2024-01-26","current":-3.861489,"twenty":-7.296337,"median":-5.106041,"eighty":-2.547996,"marketCap":188208998},{"date":"2024-02-02","current":-3.695148,"twenty":-7.269758,"median":-5.063995,"eighty":-2.553047,"marketCap":180101533},{"date":"2024-02-09","current":-3.588215,"twenty":-7.205245,"median":-4.989418,"eighty":-2.562386,"marketCap":174889592},{"date":"2024-02-16","current":-3.718911,"twenty":-7.15702,"median":-4.86761,"eighty":-2.569752,"marketCap":181259742},{"date":"2024-02-23","current":-3.968423,"twenty":-7.141115,"median":-4.782644,"eighty":-2.574787,"marketCap":193420939},{"date":"2024-03-01","current":-5.120929,"twenty":-7.126978,"median":-4.809209,"eighty":-2.579729,"marketCap":249594086},{"date":"2024-03-08","current":-5.192218,"twenty":-7.114429,"median":-4.86761,"eighty":-2.579915,"marketCap":253068714},{"date":"2024-03-15","current":-4.859536,"twenty":-7.101574,"median":-4.916346,"eighty":-2.583683,"marketCap":236853785},{"date":"2024-03-22","current":-5.144692,"twenty":-7.095444,"median":-4.930825,"eighty":-2.589158,"marketCap":250752296},{"date":"2024-03-28","current":-4.703502,"twenty":-7.089836,"median":-4.895181,"eighty":-2.591477,"marketCap":246327089},{"date":"2024-04-05","current":-4.405231,"twenty":-7.085449,"median":-4.848419,"eighty":-2.599721,"marketCap":230706347},{"date":"2024-04-12","current":-4.462591,"twenty":-7.075967,"median":-4.782644,"eighty":-2.603221,"marketCap":233710336},{"date":"2024-04-19","current":-3.625138,"twenty":-7.052176,"median":-4.776365,"eighty":-2.611522,"marketCap":189852098},{"date":"2024-04-26","current":-3.659554,"twenty":-7.051055,"median":-4.746204,"eighty":-2.620676,"marketCap":191654491},{"date":"2024-05-03","current":-3.99224,"twenty":-7.046226,"median":-4.732967,"eighty":-2.645525,"marketCap":209077627},{"date":"2024-05-10","current":-4.095488,"twenty":-7.042536,"median":-4.709765,"eighty":-2.655033,"marketCap":214484807},{"date":"2024-05-17","current":-4.006249,"twenty":-7.031951,"median":-4.692829,"eighty":-2.658717,"marketCap":224097571},{"date":"2024-05-24","current":-3.651809,"twenty":-7.023828,"median":-4.668715,"eighty":-2.660212,"marketCap":204271245},{"date":"2024-05-31","current":-3.200703,"twenty":-7.013201,"median":-4.655071,"eighty":-2.662946,"marketCap":179037738},{"date":"2024-06-07","current":-2.674413,"twenty":-6.98883,"median":-4.622094,"eighty":-2.673339,"marketCap":149598647},{"date":"2024-06-14","current":-2.835522,"twenty":-6.957296,"median":-4.609791,"eighty":-2.674198,"marketCap":158610613},{"date":"2024-06-21","current":-2.373676,"twenty":-6.949257,"median":-4.600351,"eighty":-2.669182,"marketCap":132776309},{"date":"2024-06-28","current":-2.534785,"twenty":-6.949154,"median":-4.599198,"eighty":-2.662946,"marketCap":141788276},{"date":"2024-07-05","current":-2.545526,"twenty":-6.899852,"median":-4.564008,"eighty":-2.652004,"marketCap":142389073},{"date":"2024-07-12","current":-2.814041,"twenty":-6.88559,"median":-4.51846,"eighty":-2.608794,"marketCap":157409018},{"date":"2024-07-15","current":-3.028853,"twenty":-6.885106,"median":-4.51846,"eighty":-2.610652,"marketCap":169424973},{"date":"2024-08-02","current":-3.469219,"twenty":-6.884691,"median":-4.51846,"eighty":-2.611522,"marketCap":194057682},{"date":"2024-08-09","current":-2.942928,"twenty":-6.879299,"median":-4.495685,"eighty":-2.620676,"marketCap":164618591},{"date":"2024-08-16","current":-2.385074,"twenty":-6.863694,"median":-4.477268,"eighty":-2.603221,"marketCap":154705428},{"date":"2024-08-23","current":-2.602741,"twenty":-6.860444,"median":-4.459078,"eighty":-2.601639,"marketCap":168824176},{"date":"2024-08-30","current":-2.602741,"twenty":-6.848113,"median":-4.436471,"eighty":-2.601639,"marketCap":168824176},{"date":"2024-09-06","current":-2.10257,"twenty":-6.808005,"median":-4.418252,"eighty":-2.589519,"marketCap":136381096},{"date":"2024-09-13","current":-2.269294,"twenty":-6.789035,"median":-4.418252,"eighty":-2.579729,"marketCap":147195456},{"date":"2024-09-20","current":-2.389705,"twenty":-6.77836,"median":-4.405231,"eighty":-2.565691,"marketCap":155005827},{"date":"2024-09-27","current":-2.250769,"twenty":-6.772661,"median":-4.391706,"eighty":-2.545526,"marketCap":145993860},{"date":"2024-10-04","current":-2.213719,"twenty":-6.763825,"median":-4.381813,"eighty":-2.537904,"marketCap":143590669},{"date":"2024-10-11","current":-2.084045,"twenty":-6.75499,"median":-4.351551,"eighty":-2.52363,"marketCap":135179500},{"date":"2024-10-18","current":-2.463804,"twenty":-6.75036,"median":-4.324868,"eighty":-2.493172,"marketCap":159812209},{"date":"2024-10-25","current":-2.537904,"twenty":-6.746336,"median":-4.303834,"eighty":-2.493172,"marketCap":164618591},{"date":"2024-10-31","current":-2.806514,"twenty":-6.74619,"median":-4.290341,"eighty":-2.499318,"marketCap":182041727},{"date":"2024-11-08","current":-2.936188,"twenty":-6.746154,"median":-4.256095,"eighty":-2.501671,"marketCap":190452896},{"date":"2024-11-15","current":-1.919975,"twenty":-6.744338,"median":-4.235757,"eighty":-2.492861,"marketCap":156808220},{"date":"2024-11-22","current":-1.699288,"twenty":-6.743884,"median":-4.184437,"eighty":-2.487273,"marketCap":138784287},{"date":"2024-11-29","current":-1.669864,"twenty":-6.738951,"median":-4.141738,"eighty":-2.476886,"marketCap":136381096},{"date":"2024-12-06","current":-1.55952,"twenty":-6.732888,"median":-4.12513,"eighty":-2.463368,"marketCap":127369129},{"date":"2024-12-13","current":-1.522739,"twenty":-6.729504,"median":-4.092174,"eighty":-2.444359,"marketCap":124365140},{"date":"2024-12-20","current":-1.324121,"twenty":-6.714601,"median":-4.072455,"eighty":-2.437306,"marketCap":108143600},{"date":"2024-12-27","current":-1.390327,"twenty":-6.700464,"median":-4.039868,"eighty":-2.401761,"marketCap":113550780},{"date":"2025-01-03","current":-1.360902,"twenty":-6.686699,"median":-4.021508,"eighty":-2.390383,"marketCap":111147589},{"date":"2025-01-10","current":-1.250559,"twenty":-6.66094,"median":-4.007046,"eighty":-2.380443,"marketCap":102135622},{"date":"2025-01-17","current":-1.184353,"twenty":-6.644542,"median":-4.002969,"eighty":-2.373676,"marketCap":96728442},{"date":"2025-01-24","current":-1.272627,"twenty":-6.614962,"median":-3.980769,"eighty":-2.352041,"marketCap":103938015},{"date":"2025-01-31","current":-1.147571,"twenty":-6.580597,"median":-3.965855,"eighty":-2.338607,"marketCap":93724453},{"date":"2025-02-07","current":-1.081365,"twenty":-6.566786,"median":-3.94466,"eighty":-2.323016,"marketCap":88317273},{"date":"2025-02-14","current":-1.074009,"twenty":-6.564899,"median":-3.918151,"eighty":-2.312943,"marketCap":87716475},{"date":"2025-02-21","current":-1.015159,"twenty":-6.562308,"median":-3.912497,"eighty":-2.301318,"marketCap":82910093},{"date":"2025-02-28","current":-0.926885,"twenty":-6.560601,"median":-3.900465,"eighty":-2.293717,"marketCap":75700520},{"date":"2025-03-07","current":-0.912172,"twenty":-6.556757,"median":-3.891331,"eighty":-2.270478,"marketCap":74498924},{"date":"2025-03-14","current":-0.89746,"twenty":-6.544785,"median":-3.876972,"eighty":-2.264162,"marketCap":73297329},{"date":"2025-03-21","current":-0.868035,"twenty":-6.535112,"median":-3.858033,"eighty":-2.256474,"marketCap":70894138},{"date":"2025-03-28","current":-0.728096,"twenty":-6.530944,"median":-3.854577,"eighty":-2.230367,"marketCap":74505312},{"date":"2025-04-04","current":-0.584844,"twenty":-6.525172,"median":-3.844144,"eighty":-2.213719,"marketCap":59846543},{"date":"2025-04-11","current":-0.603787,"twenty":-6.521372,"median":-3.829108,"eighty":-2.194295,"marketCap":61784893},{"date":"2025-04-17","current":-0.580109,"twenty":-6.515538,"median":-3.829108,"eighty":-2.181634,"marketCap":59361956},{"date":"2025-04-25","current":-0.651143,"twenty":-6.502285,"median":-3.796141,"eighty":-2.168921,"marketCap":66630767},{"date":"2025-05-02","current":-0.633384,"twenty":-6.492658,"median":-3.771671,"eighty":-2.161623,"marketCap":64813564},{"date":"2025-05-09","current":-0.591948,"twenty":-6.483739,"median":-3.736733,"eighty":-2.105653,"marketCap":60573425},{"date":"2025-05-16","current":-0.526263,"twenty":-6.462771,"median":-3.718911,"eighty":-2.026703,"marketCap":61179159},{"date":"2025-05-23","current":-0.536684,"twenty":-6.443969,"median":-3.695118,"eighty":-1.923456,"marketCap":62390627},{"date":"2025-05-30","current":-0.547105,"twenty":-6.440173,"median":-3.689743,"eighty":-1.875701,"marketCap":63602096},{"date":"2025-06-06","current":-0.557526,"twenty":-6.43497,"median":-3.671385,"eighty":-1.8063,"marketCap":64813564},{"date":"2025-06-13","current":-0.594,"twenty":-6.426936,"median":-3.659529,"eighty":-1.76974,"marketCap":69053704},{"date":"2025-06-20","current":-0.635684,"twenty":-6.40475,"median":-3.658151,"eighty":-1.757349,"marketCap":73899578},{"date":"2025-06-27","current":-0.630474,"twenty":-6.383401,"median":-3.651809,"eighty":-1.742663,"marketCap":73293844},{"date":"2025-07-03","current":-0.604421,"twenty":-6.374855,"median":-3.648082,"eighty":-1.728566,"marketCap":70265173},{"date":"2025-07-11","current":-0.677369,"twenty":-6.371048,"median":-3.630874,"eighty":-1.703143,"marketCap":78745452},{"date":"2025-07-18","current":-0.771158,"twenty":-6.367097,"median":-3.618507,"eighty":-1.692733,"marketCap":89648669},{"date":"2025-07-25","current":-0.838895,"twenty":-6.362679,"median":-3.608934,"eighty":-1.669864,"marketCap":97523214},{"date":"2025-08-01","current":-0.729474,"twenty":-6.358261,"median":-3.598348,"eighty":-1.652677,"marketCap":84802795},{"date":"2025-08-08","current":-0.739895,"twenty":-6.353843,"median":-3.584215,"eighty":-1.644081,"marketCap":86014263},{"date":"2025-08-15","current":-0.620516,"twenty":-6.351694,"median":-3.541925,"eighty":-1.621417,"marketCap":84802795},{"date":"2025-08-22","current":-0.602787,"twenty":-6.348535,"median":-3.530944,"eighty":-1.613202,"marketCap":82379858}],"updateTime":1756139789837},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ABOS\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2544964524","title":"Acumen Pharmaceuticals Initiated at Buy by Citigroup","url":"https://stock-news.laohu8.com/highlight/detail?id=2544964524","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544964524?lang=en_us&edition=fundamental","pubTime":"2025-06-17 19:45","pubTimestamp":1750160700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABOS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  June 17, 2025 07:45 ET (11:45 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS","BK4539","BK4139"],"gpt_icon":0},{"id":"2544968914","title":"Acumen initiated with a Buy at Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2544968914","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2544968914?lang=en_us&edition=fundamental","pubTime":"2025-06-17 17:25","pubTimestamp":1750152321,"startTime":"0","endTime":"0","summary":"Citi initiated coverage of Acumen (ABOS) (ACUM) with a Buy rating and $4 price target Acumen is a clinical stage biotech company currently developi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/acumen-initiated-with-a-buy-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/acumen-initiated-with-a-buy-at-citi-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4139","ABOS"],"gpt_icon":0},{"id":"2541700653","title":"Acumen Pharmaceuticals Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2541700653","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2541700653?lang=en_us&edition=fundamental","pubTime":"2025-06-06 04:37","pubTimestamp":1749155853,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals Inc. held its annual meeting of stockholders on June 4, 2025. During the meeting, stockholders elected Kimberlee C. Drapkin, Jeffrey Ives, Ph.D., and Sean Stalfort as Class I directors. Additionally, the stockholders ratified the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. Both proposals were approved.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Acumen Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 05, 2025, and is solely responsible for the informat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250605:nNDL9Bxy6h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0},{"id":"2535779225","title":"Acumen Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2535779225","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535779225?lang=en_us&edition=fundamental","pubTime":"2025-05-13 21:31","pubTimestamp":1747143107,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings SummaryAcumen Pharmaceuticals Inc ABOS.OQ reported a quarterly adjusted loss of 48 cents per share for the quarter ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nL8N3RL1L1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS"],"gpt_icon":0},{"id":"2535225147","title":"Acumen Pharmaceuticals Inc. Unveils Presentation on Sabirnetug Antibody Targeting Toxic Amyloid Beta Oligomers for Early Alzheimer's Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2535225147","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535225147?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:45","pubTimestamp":1747136757,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals Inc. Unveils Presentation on Sabirnetug Antibody Targeting Toxic Amyloid Beta Oligomers for Early Alzheimer's Treatment. Acumen Pharmaceuticals Inc. has released a corporate presentation focused on its development of sabirnetug , a monoclonal antibody highly selective for toxic amyloid beta oligomers. This next-generation antibody targets early-stage Alzheimer's Disease and has shown positive results in Phase 1 clinical trials. The company anticipates Phase 2 topline results by late 2026. The presentation highlights a significant and growing market for early Alzheimer's Disease treatment, driven by an aging population, improved diagnostic capabilities, and an increase in available treatment options. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for inform","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDL5W3xMR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0},{"id":"2535259457","title":"Acumen Pharmaceuticals Q1 GAAP EPS $(0.48) Beats $(0.54) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535259457","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535259457?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:00","pubTimestamp":1747134059,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals (NASDAQ:ABOS) reported quarterly losses of $(0.48) per share which beat the analyst consensus estimate of $(0.54) by 11.11 percent. This is a 92 percent decrease over losses of $(0.25) per share","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45371219/acumen-pharmaceuticals-q1-gaap-eps-0-48-beats-0-54-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS"],"gpt_icon":0},{"id":"2535723773","title":"BRIEF-Acumen Pharmaceuticals, Inc. Q1 Income From Operations USD -30.37 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2535723773","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535723773?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:00","pubTimestamp":1747134049,"startTime":"0","endTime":"0","summary":"BRIEF-Acumen Pharmaceuticals, Inc. Q1 Income From Operations USD -30.37 Million\n\n\nMay 13 (Reuters) - Acumen Pharmaceuticals, Inc. Q1 basic EPS USD -0.48.\n\nQ1 net income USD -28.796 million\nQ1 operating expenses USD 30.37 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nPLX06A690:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS","BK4539","BK4139"],"gpt_icon":0},{"id":"2535723777","title":"Acumen Pharmaceuticals Reports Q1 2025 Net Loss of $28.8 Million, Doubling from Previous Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2535723777","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535723777?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:00","pubTimestamp":1747134038,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, reported a net loss of $28.8 million for the first quarter of 2025, compared to a net loss of $14.9 million in the same period of 2024. The company holds cash, cash equivalents, and marketable securities totaling $197.9 million as of March 31, 2025, which is expected to support its clinical and operational activities into early 2027. In significant business developments, Acumen has fully enrolled its ALTITUDE-AD Phase 2 study, which investigates the efficacy, safety, and tolerability of sabirnetug for treating early Alzheimer's disease. The study includes 542 participants, and the company anticipates reporting topline results in late 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, invest","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDL9Tndcd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","BK4588","LU2210149790.SGD","LU2210150020.SGD","BK4139","IE00B3QW5Z07.USD","NDAQ","IE00B64PRP62.GBP","LU2095319765.USD","BK4539","ABOS","BK4585","BK4112","IE00BGHQF748.EUR"],"gpt_icon":0},{"id":"2535572695","title":"Press Release: Acumen Pharmaceuticals Reports First Quarter 2025 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2535572695","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535572695?lang=en_us&edition=fundamental","pubTime":"2025-05-13 19:00","pubTimestamp":1747134000,"startTime":"0","endTime":"0","summary":"-- Expect to report topline results for ALTITUDE-AD, a Phase 2 study to. investigate sabirnetug  for the treatment of early Alzheimer's. -- Cash, cash equivalents and marketable securities of $197.9 million as of. March 31, 2025, expected to support current clinical and operational. NEWTON, Mass., May 13, 2025  -- Acumen Pharmaceuticals, Inc.  , a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers  for the treatment of Alzheimer's disease , today reported financial results for the first quarter of 2025 and provided a business update.sabirnetug on synaptic biomarkers in AD, methods of interrogating","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","ABOS","AAN","BK4178"],"gpt_icon":0},{"id":"2534430218","title":"Acumen Pharmaceuticals Inc  expected to post a loss of 54 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2534430218","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2534430218?lang=en_us&edition=fundamental","pubTime":"2025-05-10 00:26","pubTimestamp":1746807965,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals Inc  expected to post a loss of54cents a share - Earnings Preview Acumen Pharmaceuticals Inc ABOS.OQ ABOS.O is expected to show no change in quarterly revenue when it reports  r","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250509:nL8N3RH2QV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS"],"gpt_icon":0},{"id":"2523689127","title":"Acumen Pharmaceuticals’ Promising Alzheimer’s Strategy Earns Buy Rating with Revised Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2523689127","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2523689127?lang=en_us&edition=fundamental","pubTime":"2025-03-29 01:55","pubTimestamp":1743184513,"startTime":"0","endTime":"0","summary":"Andrew Fein, an analyst from H.C. Wainwright, maintained the Buy rating on Acumen Pharmaceuticals (ABOS – Research Report). The associated price ta...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/acumen-pharmaceuticals-promising-alzheimers-strategy-earns-buy-rating-with-revised-price-target?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/acumen-pharmaceuticals-promising-alzheimers-strategy-earns-buy-rating-with-revised-price-target?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ABOS"],"gpt_icon":0},{"id":"2522579920","title":"Acumen Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2522579920","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522579920?lang=en_us&edition=fundamental","pubTime":"2025-03-28 20:45","pubTimestamp":1743165900,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ABOS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  March 28, 2025 08:45 ET (12:45 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS"],"gpt_icon":0},{"id":"2522410527","title":"UBS Cuts Price Target on Acumen Pharmaceuticals to $4 From $6, Keeps Buy Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2522410527","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522410527?lang=en_us&edition=fundamental","pubTime":"2025-03-28 19:23","pubTimestamp":1743161015,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals (ABOS) has an average rating of buy and mean price target of $8.75, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ABOS"],"gpt_icon":0},{"id":"2522351488","title":"Acumen Pharmaceuticals Inc (ABOS) Q4 2024 Earnings Call Highlights: Strong Financial Position ...","url":"https://stock-news.laohu8.com/highlight/detail?id=2522351488","media":"GuruFocus.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522351488?lang=en_us&edition=fundamental","pubTime":"2025-03-28 15:01","pubTimestamp":1743145262,"startTime":"0","endTime":"0","summary":"Cash and Marketable Securities: $231.5 million as of the end of 2024.R&D Expenses: $93.8 million in 2024, increased due to ALTITUDE-AD trial support.G&A Expenses: $20.2 million in 2024, roughly flat compared to the prior year.Net Loss: $102.3 million in 2024, after accounting for interest income.GuruFocus has detected 3 Warning Signs with ABOS.For the complete transcript of the earnings call, please refer to the full earnings call transcript.Acumen Pharmaceuticals Inc  successfully completed enrollment of 542 participants in the ALTITUDE-AD Phase II study ahead of schedule, demonstrating strong operational execution.Acumen Pharmaceuticals Inc  has a strong financial position with $231.5 million in cash and marketable securities, expected to support operations into the first half of 2027.The company is actively engaging with the research community and clinical investigators, enhancing the recognition and potential of sabirnetug as a next-generation treatment for early Alzheimer's diseas","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acumen-pharmaceuticals-inc-abos-q4-070102406.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ABOS"],"gpt_icon":0},{"id":"2522590379","title":"Q4 2024 Acumen Pharmaceuticals Inc Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2522590379","media":"Thomson Reuters StreetEvents","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522590379?lang=en_us&edition=fundamental","pubTime":"2025-03-28 13:00","pubTimestamp":1743138047,"startTime":"0","endTime":"0","summary":"Alex Braun; Head of Investor Relations; Acumen Pharmaceuticals Inc. Daniel O'Connell; Chief Executive Officer, Director; Acumen Pharmaceuticals Inc. W. Matthew Zuga; Chief Financial Officer, Chief Business Officer; Acumen Pharmaceuticals Inc. James Doherty; President, Chief Development Officer; Acumen Pharmaceuticals Inc. Eric Siemers; Chief Medical Officer; Acumen Pharmaceuticals Inc. Thanks, Alex. Good morning, everyone, and thanks for joining us today. Acumen entered 2024 from a position of strength, stemming from our positive results for sabirnetug in our INTERCEPT-AD Phase I study in early Alzheimer's patients. In INTERCEPT AD, sabirnetug was well tolerated, demonstrated novel target engagement of A-beta oligomers and produce consistent effects on imaging and fluid biomarkers in a dose-dependent manner.I'm proud though not surprised that our talented team leaned into this","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/q4-2024-acumen-pharmaceuticals-inc-050047124.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ABOS"],"gpt_icon":0},{"id":"2522095173","title":"Acumen Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2522095173","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522095173?lang=en_us&edition=fundamental","pubTime":"2025-03-27 21:31","pubTimestamp":1743082268,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings SummaryAcumen Pharmaceuticals Inc ABOS.OQ reported a quarterly adjusted loss of 62 cents per share for the quart","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nL5N3QA18Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS"],"gpt_icon":0},{"id":"2522759743","title":"Acumen Pharmaceuticals FY 2024 EPS $(1.71) Misses $(1.55) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2522759743","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522759743?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:03","pubTimestamp":1743073423,"startTime":"0","endTime":"0","summary":"Acumen Pharmaceuticals (NASDAQ:ABOS) reported FY 2024 EPS $(1.71) Misses $(1.55) Estimate.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44510836/acumen-pharmaceuticals-fy-2024-eps-1-71-misses-1-55-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS"],"gpt_icon":0},{"id":"2522667375","title":"BRIEF-Acumen Pharmaceuticals, Inc. FY Income From Operations USD -114.017 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2522667375","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522667375?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:00","pubTimestamp":1743073246,"startTime":"0","endTime":"0","summary":"BRIEF-Acumen Pharmaceuticals, Inc. FY Income From Operations USD -114.017 Million\n\n\nMar 27 (Reuters) - Acumen Pharmaceuticals, Inc. FY net income USD -102.329 million.\n\nFY operating expenses USD 114.017 million\nFY basic EPS USD -1.71","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250327:nPLX40B324:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ABOS","BK4139","BK4539"],"gpt_icon":0},{"id":"2522759233","title":"Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2024 and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2522759233","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522759233?lang=en_us&edition=fundamental","pubTime":"2025-03-27 19:00","pubTimestamp":1743073200,"startTime":"0","endTime":"0","summary":"Enrollment complete for ALTITUDE-AD, a Phase 2 study to investigate sabirnetug  for the treatment of early Alzheimer’s disease. Topline results from the Phase 1 study investigating a subcutaneous sabirnetug formulation support further development of this dosing option for patients. Cash, cash equivalents and marketable securities of $231.5 million as of Dec. 31, 2024, expected to support current clinical and operational activities into the first half of 2027. In January 2025, the Company announced that the Journal of Prevention of Alzheimer’s Disease  published the results of its Phase 1 INTERCEPT-AD study, demonstrating that sabirnetug  was generally well-tolerated with dose- and exposure-dependent target engagement and reduction in amyloid plaques.The publication titled “INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's disease” is available online here.The publication titled “Biofluid biomarker ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/acumen-pharmaceuticals-reports-financial-results-110000269.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","ABOS","BK4539"],"gpt_icon":0},{"id":"2522742168","title":"BRIEF-Acumen Pharmaceuticals Completes Enrollment Of Altitude-Ad, A Phase 2 Clinical Trial Of Sabirnetug (Acu193) In Early Alzheimer’S Disease","url":"https://stock-news.laohu8.com/highlight/detail?id=2522742168","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522742168?lang=en_us&edition=fundamental","pubTime":"2025-03-26 20:07","pubTimestamp":1742990844,"startTime":"0","endTime":"0","summary":"BRIEF-Acumen Pharmaceuticals Completes Enrollment Of Altitude-Ad, A Phase 2 Clinical Trial Of Sabirnetug (Acu193) In Early Alzheimer’S DiseaseMarch 26 (Reuters) - Acumen Pharmaceuticals Inc ABOS.O:ACU","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250326:nTUA7DG50M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","ABOS","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":2,"totalSize":47,"code":"91000000","status":"200"}]}}